Back to News
Market Impact: 0.12

La production en série de Xatryx® de CovationBio respecte les spécifications ; la première semelle de chaussures de sport biosourcée non alimentaire sera présentée au salon NW Materials aux États-Unis.

Source: PR Newswire

ESG & Climate PolicyRenewable Energy TransitionTechnology & InnovationCompany Fundamentals

CovationBio announced it has successfully produced its first commercial batch lots of bioTHF Xatryx.T and bioPTMEG Xatryx®, both compliant with customer requirements/standards referenced in the release. The event signals progress in scaling biosourced materials production, supporting product readiness and potential future commercialization. The excerpt does not provide financial figures, so likely price impact is limited at this stage.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.25

More News

From AllMind Research

Browse all research